Cargando…
SARS-CoV-2 vaccine development
SARS-CoV-2 is a well-known viral strain that causes COVID-19. The disease became a pandemic in early 2020 and infected millions of people and killed hundreds of thousands of people worldwide. Vaccine development against the disease was accelerated with multiple collaborations among research institut...
Autores principales: | Mtewa, Andrew G., Amanjot, Annu, Lampiao, Fanuel, Okella, Hedmon, Weisheit, Anke, Tolo, Casim U., Ogwang, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217717/ http://dx.doi.org/10.1016/B978-0-323-85156-5.00046-8 |
Ejemplares similares
-
Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing
por: Mtewa, Andrew G., et al.
Publicado: (2021) -
Pharmacology, Phytochemistry, and Toxicity Profiles of
Phytolacca dodecandra L’Hér: A Scoping
Review
por: Beressa, Tamirat Bekele, et al.
Publicado: (2020) -
Drug repurposing for SARS-CoV-2 (COVID-19) treatment
por: Mtewa, Andrew G., et al.
Publicado: (2022) -
Potential Benefits of Antiviral African Medicinal Plants in the Management of Viral Infections: Systematic Review
por: Beressa, Tamirat Bekele, et al.
Publicado: (2021) -
ADMET profiling and molecular docking of potential antimicrobial peptides previously isolated from African catfish, Clarias gariepinus
por: Okella, Hedmon, et al.
Publicado: (2022)